QA: Dermata Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001853816_2023_Dermata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001853816', 'EntityCommonStockSharesOutstanding': 12102214, 'Assets': 6944488, 'AssetsCurrent': 0, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 922634, 'LiabilitiesAndStockholdersEquity': 6944488, 'LiabilitiesCurrent': 496702, 'LiabilitiesNoncurrent': 0, 'NetIncome': -9610913, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 6944488, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 425932, 'remainder_LiabilitiesAndStockholdersEquity': 6021854, 'remainder_NetIncome': -9610913, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Edgar->Model Mapping